Related Articles
Seventeen years of experience with ATRA-based therapy for acute promyelocytic leukaemia: Long-term follow-up of patients treated at S. Martino Hospital, Genoa
Treatment outcomes in relapsed acute promyelocytic leukemia patients initially treated with all‑trans retinoic acid and arsenic compound‑based combined therapies
Efficacy of all-trans retinoic acid for molecular relapse of acute promyelocytic leukemia during remission.
Influence of initiation time and white blood cell count on the efficacy of cytotoxic agents in acute promyelocytic leukemia during induction treatment
The novel three‑way variant t(6;17;15)(p21;q21;q22) in acute promyelocytic leukemia with an FLT3‑ITD mutation: A case report